£305
−74%vs Apr 2024Active14069254Private limited companyWembley
RUBIEPHARMA LTD
Significant control: Jaafar Ali Al-Rubie (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Rubiepharma Ltd sell?
Registered activity: Dispensing chemist in specialised stores (SIC 47730). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
RUBIEPHARMA LTD is an active private limited company (company number 14069254) incorporated on 26 April 2022, registered in Wembley. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest micro accounts cover the period ending 30 April 2025, showing net assets of £305, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 74% on the prior period (£1,185).
Peer position · net assets
By net assets it sits in the lower half of 900 comparable companies in Greater London (median £16k, upper quartile £276k).
02
Ownership and control
- Mr Jaafar Ali Al-Rubie
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 26 April 20224 yrs ago
- Next accounts due
- 30 January 2027in 99 days
- Confirmation statement due
- 10 May 2027in 199 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £305 | — | — | £804 | — | — | 0 |
| 30 April 2024 | £1,185 | — | — | £3,401 | — | — | 0 |
Current ratio0.41Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £305 at 30 April 2025
- Net assets down 25% or more on the prior period-74.3% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.41
- Incorporated two to five years agoIncorporated 26 April 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 199 days
- Next accounts duein 99 days
- Accounts period endNet assets £305 · micro accounts
- Accounts period endNet assets £1,185 · micro accounts
- Incorporated
08
Similar companies in Greater London
09
Reminders for RUBIEPHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.